QQQ   283.85 (+1.18%)
AAPL   142.65 (+1.21%)
MSFT   247.40 (+1.24%)
META   115.33 (+1.23%)
GOOGL   93.71 (-1.30%)
AMZN   90.35 (+2.14%)
TSLA   173.44 (-0.34%)
NVDA   171.69 (+6.51%)
NIO   13.41 (+6.60%)
BABA   94.17 (+6.61%)
AMD   70.47 (+0.47%)
T   19.12 (-0.93%)
MU   55.20 (+2.56%)
CGC   3.09 (-4.63%)
F   13.12 (+0.15%)
GE   83.63 (-1.61%)
DIS   92.55 (+0.43%)
AMC   6.07 (+0.33%)
PYPL   74.22 (-0.27%)
PFE   51.78 (+3.07%)
NFLX   310.26 (+0.60%)
QQQ   283.85 (+1.18%)
AAPL   142.65 (+1.21%)
MSFT   247.40 (+1.24%)
META   115.33 (+1.23%)
GOOGL   93.71 (-1.30%)
AMZN   90.35 (+2.14%)
TSLA   173.44 (-0.34%)
NVDA   171.69 (+6.51%)
NIO   13.41 (+6.60%)
BABA   94.17 (+6.61%)
AMD   70.47 (+0.47%)
T   19.12 (-0.93%)
MU   55.20 (+2.56%)
CGC   3.09 (-4.63%)
F   13.12 (+0.15%)
GE   83.63 (-1.61%)
DIS   92.55 (+0.43%)
AMC   6.07 (+0.33%)
PYPL   74.22 (-0.27%)
PFE   51.78 (+3.07%)
NFLX   310.26 (+0.60%)
QQQ   283.85 (+1.18%)
AAPL   142.65 (+1.21%)
MSFT   247.40 (+1.24%)
META   115.33 (+1.23%)
GOOGL   93.71 (-1.30%)
AMZN   90.35 (+2.14%)
TSLA   173.44 (-0.34%)
NVDA   171.69 (+6.51%)
NIO   13.41 (+6.60%)
BABA   94.17 (+6.61%)
AMD   70.47 (+0.47%)
T   19.12 (-0.93%)
MU   55.20 (+2.56%)
CGC   3.09 (-4.63%)
F   13.12 (+0.15%)
GE   83.63 (-1.61%)
DIS   92.55 (+0.43%)
AMC   6.07 (+0.33%)
PYPL   74.22 (-0.27%)
PFE   51.78 (+3.07%)
NFLX   310.26 (+0.60%)
QQQ   283.85 (+1.18%)
AAPL   142.65 (+1.21%)
MSFT   247.40 (+1.24%)
META   115.33 (+1.23%)
GOOGL   93.71 (-1.30%)
AMZN   90.35 (+2.14%)
TSLA   173.44 (-0.34%)
NVDA   171.69 (+6.51%)
NIO   13.41 (+6.60%)
BABA   94.17 (+6.61%)
AMD   70.47 (+0.47%)
T   19.12 (-0.93%)
MU   55.20 (+2.56%)
CGC   3.09 (-4.63%)
F   13.12 (+0.15%)
GE   83.63 (-1.61%)
DIS   92.55 (+0.43%)
AMC   6.07 (+0.33%)
PYPL   74.22 (-0.27%)
PFE   51.78 (+3.07%)
NFLX   310.26 (+0.60%)
NYSE:NUS

Nu Skin Enterprises - NUS Stock Forecast, Price & News

$40.52
-0.46 (-1.12%)
(As of 12/8/2022 12:00 AM ET)
Add
Compare
Today's Range
$40.45
$41.68
50-Day Range
$31.79
$42.45
52-Week Range
$29.95
$56.76
Volume
449,370 shs
Average Volume
614,509 shs
Market Capitalization
$2.00 billion
P/E Ratio
54.76
Dividend Yield
3.76%
Price Target
$48.00

Nu Skin Enterprises MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
18.5% Upside
$48.00 Price Target
Short Interest
Healthy
4.05% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-2.56
Upright™ Environmental Score
News Sentiment
0.63mentions of Nu Skin Enterprises in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$1.07 M Sold Last Quarter
Proj. Earnings Growth
16.93%
From $2.54 to $2.97 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.72 out of 5 stars

Consumer Staples Sector

22nd out of 141 stocks

Drugs, Proprietaries, & Sundries Industry

3rd out of 6 stocks

NUS stock logo

About Nu Skin Enterprises (NYSE:NUS) Stock

Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, LifePak nutritional supplements, ageLOC Meta nutritional supplements, and Beauty Focus Collagen+ skin care supplements, as well as other weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

Receive NUS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nu Skin Enterprises and its competitors with MarketBeat's FREE daily newsletter.

NUS Stock News Headlines

Nu Skin Enterprises (NYSE:NUS) Shares Down 4.4%
Stifel Nicolaus Keeps Their Hold Rating on Nu Skin (NUS)
NU Skin Enterprises is Oversold
Nu Skin Enterprises Inc.
Nu Skin (NUS) Down More Than 15% in 3 Months: Here's Why
See More Headlines
Receive NUS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nu Skin Enterprises and its competitors with MarketBeat's FREE daily newsletter.

NUS Company Calendar

Last Earnings
11/02/2022
Ex-Dividend for 12/7 Dividend
11/23/2022
Dividend Payable
12/07/2022
Today
12/08/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/15/2023

Industry, Sector and Symbol

Industry
Drugs, proprietaries, & sundries
Sub-Industry
Personal Products
CUSIP
67018T10
Employees
4,600
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$48.00
High Stock Price Forecast
$75.00
Low Stock Price Forecast
$34.00
Forecasted Upside/Downside
+18.5%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Net Income
$147.27 million
Pretax Margin
3.49%

Debt

Sales & Book Value

Annual Sales
$2.70 billion
Cash Flow
$5.68 per share
Book Value
$18.29 per share

Miscellaneous

Free Float
48,036,000
Market Cap
$2.00 billion
Optionable
Optionable
Beta
1.23

Key Executives

  • Mr. Steven J. Lund (Age 69)
    Exec. Chairman
    Comp: $827.03k
  • Mr. Ryan S. Napierski (Age 48)
    Pres, CEO & Director
    Comp: $1.46M
  • Mr. Mark H. Lawrence (Age 52)
    Exec. VP & CFO
    Comp: $918.58k
  • Dr. Joseph Y. Chang Ph.D. (Age 69)
    Exec. VP & Chief Scientific Officer
    Comp: $1.13M
  • Mr. Chayce David Clark (Age 39)
    Exec. VP & Gen. Counsel
    Comp: $540.92k
  • Mr. Ritch N. WoodMr. Ritch N. Wood (Age 56)
    Exec. Advisor
    Comp: $1.53M
  • Mr. D. Matthew DornyMr. D. Matthew Dorny (Age 58)
    Legal Advisor
    Comp: $687.56k
  • Ms. Mang Yee Tang (Age 51)
    Exec. VP and Chief Global Growth & Customer Experience Officer
    Comp: $796.45k
  • Mr. Blake M. Roney (Age 63)
    Founder
  • Ms. Sandra N. Tillotson (Age 65)
    Founder













NUS Stock - Frequently Asked Questions

Should I buy or sell Nu Skin Enterprises stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Nu Skin Enterprises in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" NUS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NUS, but not buy additional shares or sell existing shares.
View NUS analyst ratings
or view top-rated stocks.

What is Nu Skin Enterprises' stock price forecast for 2023?

2 equities research analysts have issued 1-year price targets for Nu Skin Enterprises' shares. Their NUS share price forecasts range from $34.00 to $75.00. On average, they predict the company's share price to reach $48.00 in the next year. This suggests a possible upside of 18.5% from the stock's current price.
View analysts price targets for NUS
or view top-rated stocks among Wall Street analysts.

How have NUS shares performed in 2022?

Nu Skin Enterprises' stock was trading at $50.75 on January 1st, 2022. Since then, NUS shares have decreased by 20.2% and is now trading at $40.52.
View the best growth stocks for 2022 here
.

Are investors shorting Nu Skin Enterprises?

Nu Skin Enterprises saw a decrease in short interest in the month of November. As of November 15th, there was short interest totaling 1,960,000 shares, a decrease of 46.6% from the October 31st total of 3,670,000 shares. Based on an average daily volume of 526,700 shares, the days-to-cover ratio is presently 3.7 days. Approximately 4.1% of the shares of the stock are short sold.
View Nu Skin Enterprises' Short Interest
.

When is Nu Skin Enterprises' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 15th 2023.
View our NUS earnings forecast
.

How were Nu Skin Enterprises' earnings last quarter?

Nu Skin Enterprises, Inc. (NYSE:NUS) issued its quarterly earnings results on Wednesday, November, 3rd. The company reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.86 by $0.11. The company had revenue of $641.15 million for the quarter, compared to analyst estimates of $639.19 million. Nu Skin Enterprises had a net margin of 1.61% and a trailing twelve-month return on equity of 17.44%. During the same quarter last year, the firm posted $1.08 earnings per share.

How often does Nu Skin Enterprises pay dividends? What is the dividend yield for Nu Skin Enterprises?

Nu Skin Enterprises announced a quarterly dividend on Wednesday, November 2nd. Stockholders of record on Friday, November 25th will be given a dividend of $0.385 per share on Wednesday, December 7th. This represents a $1.54 dividend on an annualized basis and a yield of 3.80%. The ex-dividend date is Wednesday, November 23rd.
Read our dividend analysis for NUS
.

Is Nu Skin Enterprises a good dividend stock?

Nu Skin Enterprises (NYSE:NUS) pays an annual dividend of $1.54 per share and currently has a dividend yield of 3.76%. The company has been increasing its dividend for 21 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 208.11%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, NUS will have a dividend payout ratio of 51.85% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for NUS.

What guidance has Nu Skin Enterprises issued on next quarter's earnings?

Nu Skin Enterprises updated its fourth quarter 2022 earnings guidance on Wednesday, November, 9th. The company provided earnings per share (EPS) guidance of $0.40-$0.60 for the period, compared to the consensus earnings per share estimate of $1.09. The company issued revenue guidance of $500.00 million-$550.00 million, compared to the consensus revenue estimate of $645.47 million.

What is Ritch Wood's approval rating as Nu Skin Enterprises' CEO?

72 employees have rated Nu Skin Enterprises Chief Executive Officer Ritch Wood on Glassdoor.com. Ritch Wood has an approval rating of 91% among the company's employees. This puts Ritch Wood in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Nu Skin Enterprises own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nu Skin Enterprises investors own include Alibaba Group (BABA), General Electric (GE), NVIDIA (NVDA), Marathon Petroleum (MPC), Gilead Sciences (GILD), Alphabet (GOOG), Tesla (TSLA), Herbalife Nutrition (HLF), Mastercard (MA) and Netflix (NFLX).

What is Nu Skin Enterprises' stock symbol?

Nu Skin Enterprises trades on the New York Stock Exchange (NYSE) under the ticker symbol "NUS."

Who are Nu Skin Enterprises' major shareholders?

Nu Skin Enterprises' stock is owned by a number of institutional and retail investors. Top institutional investors include State Street Corp (19.16%), Vanguard Group Inc. (11.94%), BlackRock Inc. (11.65%), Renaissance Technologies LLC (5.15%), Dimensional Fund Advisors LP (3.82%) and Bank of New York Mellon Corp (1.71%). Insiders that own company stock include Andrew D Lipman, D Matthew Dorny, James D Thomas, Jeffrey Clark Bettinger, Joseph Y Chang, Mark H Lawrence, Ritch N Wood, Ryan S Napierski and Steven Lund.
View institutional ownership trends
.

How do I buy shares of Nu Skin Enterprises?

Shares of NUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Nu Skin Enterprises' stock price today?

One share of NUS stock can currently be purchased for approximately $40.52.

How much money does Nu Skin Enterprises make?

Nu Skin Enterprises (NYSE:NUS) has a market capitalization of $2.00 billion and generates $2.70 billion in revenue each year. The company earns $147.27 million in net income (profit) each year or $0.74 on an earnings per share basis.

How many employees does Nu Skin Enterprises have?

The company employs 4,600 workers across the globe.

How can I contact Nu Skin Enterprises?

Nu Skin Enterprises' mailing address is 75 WEST CENTER ST, PROVO UT, 84601. The official website for the company is www.nuskinenterprises.com. The company can be reached via phone at (801) 345-1000, via email at investorrelations@nuskin.com, or via fax at 801-345-5999.

This page (NYSE:NUS) was last updated on 12/8/2022 by MarketBeat.com Staff